Man Li

457 total citations
22 papers, 142 citations indexed

About

Man Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Man Li has authored 22 papers receiving a total of 142 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Man Li's work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Genomics and Diagnostics (3 papers). Man Li is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Genomics and Diagnostics (3 papers). Man Li collaborates with scholars based in China. Man Li's co-authors include Zuowei Zhao, Caigang Liu, Hao Zhang, Xuelu Li, Haixin Lei, Hui Yang, Na Li, Ning Li, Ming Sun and Yaqian Liu and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Science and Cell Death and Disease.

In The Last Decade

Man Li

19 papers receiving 140 citations

Peers

Man Li
Comparison fields: 5 of 56
  • Oncology 61
  • Molecular Biology 56
  • Cancer Research 35
  • Pulmonary and Respiratory Medicine 28
  • Pathology and Forensic Medicine 11
Replace Aniket Shetty with:
Aniket Shetty United States
Karina Vázquez-Arreguín United States
David Huntsman Canada
Ιωάννα Ακρίδα Greece
Sevilay Turan United States
Sara Waise United Kingdom
Vera M. Todd United States
Elke Pfaff Germany
Lisanne E. Nijman Netherlands
Saya H. Ebbesen United States
Aniket Shetty United States View profile →
Citations per field, relative to Man Li
Man Li · 1×
Citations per year, relative to Man Li
Man Li · 1×

Countries citing papers authored by Man Li

Since Specialization
Citations

This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).

Fields of papers citing papers by Man Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.

Co-authorship network of co-authors of Man Li

This figure shows the co-authorship network connecting the top 25 collaborators of Man Li. A scholar is included among the top collaborators of Man Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man Li. Man Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 2
3 0
4 0
5 1
6 9
7 3
8 2
9 1
10 2
11 5
12 2
13 9
14 16
15
Metastatic brain tumors respond favorably to pyrotinib in a HER2-positive breast cancer following failure using trastuzumab.
4
16 1
17 30
18 21
19 13
20 4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026